Product name | Recombinant SARS-CoV-2 envelope Protein with His and Avi tag |
---|---|
Catalog No. | RP01263 |
Description | Recombinant SARS-CoV-2(2019-nCoV) envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2(2019-nCoV) envelope (Accession #QHD43418.1) fused with an initial Met, a 6×His, Avi tag at the N-terminus. |
Bio-Activity |
Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Envelope at 2μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1.2-41.1 ng/mL. |
Purity | > 95% by SDS-PAGE. |
Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
Formulation | Supplied as a 0.22 μm filtered solution in 20mM Tris, 250mM NaCl, 0.5%TritonX-100, pH 8.0.Contact us for customized product form or formulation. |
Species | SARS-CoV-2 |
Calculated MW | 11.4kDa |
Synonym | 2019-nCoV E protein; 2019-nCoV sM protein; Envelope protein; Env polyprotein; Envelope glycoprotein; env; COVID-19; E |
---|---|
Expressed Host | E. coli |
Tag | N-6×His & Avi |
Gene ID | 43740570 |
Storage | This product is stable at ≤ -70°C for up to 6 months from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. |
---|
Submit your question about RP01263 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.
Publishing research using RP01263? Please let us know so that we can cite the reference in this datasheet.
* For research use only. Not for therapeutic or diagnostic purposes.
!OUT OF STOCK
See Below for Alternatives